Press Releases Year: - Any -2021202020192018201720162015201420132012201120102009 Items per page 102550 Date Title and Summary Additional Formats Toggle Summary Jun 17, 2014 Flexion Therapeutics Announces Positive Topline Results From Phase 2a Pharmacokinetic Trial With Lead Compound FX006 View HTML Flexion Therapeutics Announces Positive Topline Results From Phase 2a Pharmacokinetic Trial With Lead Compound FX006 19.4 KB Toggle Summary Jun 12, 2014 Flexion Therapeutics Announces Changes to Board of Directors View HTML Flexion Therapeutics Announces Changes to Board of Directors 16.4 KB Toggle Summary Jun 11, 2014 Flexion Therapeutics to Present at Wells Fargo Securities Research, Economics & Strategy 2014 Healthcare Conference View HTML Flexion Therapeutics to Present at Wells Fargo Securities Research, Economics & Strategy 2014 Healthcare Conference 14 KB Toggle Summary May 27, 2014 Flexion Therapeutics to Present at the 2014 Jefferies Healthcare Conference View HTML Flexion Therapeutics to Present at the 2014 Jefferies Healthcare Conference 14 KB Toggle Summary May 08, 2014 Flexion Therapeutics Reports First-Quarter 2014 Financial Results View HTML Flexion Therapeutics Reports First-Quarter 2014 Financial Results 26.1 KB Toggle Summary May 01, 2014 Flexion Therapeutics to Report First Quarter 2014 Financial Results on May 8, 2014 View HTML Flexion Therapeutics to Report First Quarter 2014 Financial Results on May 8, 2014 14.2 KB Toggle Summary Apr 30, 2014 Flexion Therapeutics Initiates a Phase 2b Confirmatory Dose-Ranging Trial With Lead Compound FX006 Multi-Center Trial Will Enroll Approximately 300 Patients in the U.S. for the Treatment of Pain Associated With Osteoarthritis (OA) of the Knee View HTML Flexion Therapeutics Initiates a Phase 2b Confirmatory Dose-Ranging Trial With Lead Compound FX006 18.3 KB Toggle Summary Apr 02, 2014 Flexion Therapeutics to Present at the 13th Annual Needham Healthcare Conference View HTML Flexion Therapeutics to Present at the 13th Annual Needham Healthcare Conference 14.8 KB Toggle Summary Mar 27, 2014 Flexion Reports Year-End 2013 Financial Results View HTML Flexion Reports Year-End 2013 Financial Results 27.6 KB Toggle Summary Mar 20, 2014 Flexion Therapeutics to Report Year-End 2013 Earning Results on March 27, 2014 View HTML Flexion Therapeutics to Report Year-End 2013 Earning Results on March 27, 2014 14.3 KB Pagination First page First Previous page Previous … Page 24 Current page 25 Page 26 Page 27 Next page Next Last page Last
Press Releases Year: - Any -2021202020192018201720162015201420132012201120102009 Items per page 102550 Date Title and Summary Additional Formats Toggle Summary Jun 17, 2014 Flexion Therapeutics Announces Positive Topline Results From Phase 2a Pharmacokinetic Trial With Lead Compound FX006 View HTML Flexion Therapeutics Announces Positive Topline Results From Phase 2a Pharmacokinetic Trial With Lead Compound FX006 19.4 KB Toggle Summary Jun 12, 2014 Flexion Therapeutics Announces Changes to Board of Directors View HTML Flexion Therapeutics Announces Changes to Board of Directors 16.4 KB Toggle Summary Jun 11, 2014 Flexion Therapeutics to Present at Wells Fargo Securities Research, Economics & Strategy 2014 Healthcare Conference View HTML Flexion Therapeutics to Present at Wells Fargo Securities Research, Economics & Strategy 2014 Healthcare Conference 14 KB Toggle Summary May 27, 2014 Flexion Therapeutics to Present at the 2014 Jefferies Healthcare Conference View HTML Flexion Therapeutics to Present at the 2014 Jefferies Healthcare Conference 14 KB Toggle Summary May 08, 2014 Flexion Therapeutics Reports First-Quarter 2014 Financial Results View HTML Flexion Therapeutics Reports First-Quarter 2014 Financial Results 26.1 KB Toggle Summary May 01, 2014 Flexion Therapeutics to Report First Quarter 2014 Financial Results on May 8, 2014 View HTML Flexion Therapeutics to Report First Quarter 2014 Financial Results on May 8, 2014 14.2 KB Toggle Summary Apr 30, 2014 Flexion Therapeutics Initiates a Phase 2b Confirmatory Dose-Ranging Trial With Lead Compound FX006 Multi-Center Trial Will Enroll Approximately 300 Patients in the U.S. for the Treatment of Pain Associated With Osteoarthritis (OA) of the Knee View HTML Flexion Therapeutics Initiates a Phase 2b Confirmatory Dose-Ranging Trial With Lead Compound FX006 18.3 KB Toggle Summary Apr 02, 2014 Flexion Therapeutics to Present at the 13th Annual Needham Healthcare Conference View HTML Flexion Therapeutics to Present at the 13th Annual Needham Healthcare Conference 14.8 KB Toggle Summary Mar 27, 2014 Flexion Reports Year-End 2013 Financial Results View HTML Flexion Reports Year-End 2013 Financial Results 27.6 KB Toggle Summary Mar 20, 2014 Flexion Therapeutics to Report Year-End 2013 Earning Results on March 27, 2014 View HTML Flexion Therapeutics to Report Year-End 2013 Earning Results on March 27, 2014 14.3 KB Pagination First page First Previous page Previous … Page 24 Current page 25 Page 26 Page 27 Next page Next Last page Last
Flexion Therapeutics Announces Positive Topline Results From Phase 2a Pharmacokinetic Trial With Lead Compound FX006 19.4 KB
Flexion Therapeutics to Present at Wells Fargo Securities Research, Economics & Strategy 2014 Healthcare Conference 14 KB
Flexion Therapeutics Initiates a Phase 2b Confirmatory Dose-Ranging Trial With Lead Compound FX006 18.3 KB
